SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-041984
Filing Date
2023-05-22
Accepted
2023-05-22 16:15:31
Documents
80
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0323_avalonglo.htm   iXBRL 10-Q 885064
2 CERTIFICATION f10q0323ex31-1_avalonglobo.htm EX-31.1 11163
3 CERTIFICATION f10q0323ex31-2_avalonglobo.htm EX-31.2 11601
4 CERTIFICATION f10q0323ex32-1_avalonglobo.htm EX-32.1 4331
5 CERTIFICATION f10q0323ex32-2_avalonglobo.htm EX-32.2 3861
  Complete submission text file 0001213900-23-041984.txt   5859707

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE avco-20230331.xsd EX-101.SCH 88411
7 XBRL CALCULATION FILE avco-20230331_cal.xml EX-101.CAL 44704
8 XBRL DEFINITION FILE avco-20230331_def.xml EX-101.DEF 317408
9 XBRL LABEL FILE avco-20230331_lab.xml EX-101.LAB 651569
10 XBRL PRESENTATION FILE avco-20230331_pre.xml EX-101.PRE 335131
74 EXTRACTED XBRL INSTANCE DOCUMENT f10q0323_avalonglo_htm.xml XML 601957
Mailing Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728
Business Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728 732-780-4400
Avalon GloboCare Corp. (Filer) CIK: 0001630212 (see all company filings)

IRS No.: 471685128 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38728 | Film No.: 23944605
SIC: 2836 Biological Products, (No Diagnostic Substances)